SGX Market Updates

Hi-P International, SBS Transit & Bumitama Led Mid-Cap Companies in 2019


PUBLISHED ON |

06 January 2020

  • Singapore’s Mid-Cap Stocks performed in-line with the stocks of the same market capitalisation across Asia in 2019. Of Singapore’s 40 most traded Mid-Cap Companies, 19 Companies outpaced the STI in 2019.

  • Of the 40 Mid-Cap Companies, the 5 strongest performers in 2019 included Hi-P International, SBS Transit, Bumitama Agri, SIA Engineering and Oxley Holdings. SBS Transit was also amongst the 5 best performers of the Mid-Cap Companies in 2018. 

  • The 10 Mid-Cap Companies among the group of 40 that saw the highest net institutional inflows proportionate to their year-end market capitalisation, averaged a 23% total return in 2019, with their median total return at 14%.




In 2019, Singapore’s Mid-Cap Stocks that encompass both companies and trusts performed in-line with stocks of the same range in market capitalisation across Asian exchanges. In Singapore, performances were led by the relevant sized REITs which are discussed in more detail here.

Singapore’s Mid-Cap Stocks are generally categorised as listed corporations or trusts with a market capitalisation ranging from above S$1 billion to below S$6 billion as of the end of 2019. The constituents of the FTSE ST Mid-Cap Index maintain a similar range in market capitalisation.



40 Most Traded Mid-Cap Companies in Singapore

Excluding REITs and Business Trusts, Singapore’s 40 most traded Mid-Cap Companies averaged a 10% total return in 2019, with their median total return at 7%. The performance of these 40 Companies was, on average, in-line with the returns of the Straits Times Index (STI) as discussed here. In total, 19 of the Companies outpaced the STI with an average 24% total return, while 21 Companies did not keep in pace with the STI averaging a 3% decline in total return.

The group of 40 Mid-Cap companies include six current constituents of the STI. However the 5 strongest performing of the 40 stocks in 2019 were all non-STI stocks. These 5 stocks were Hi-P International, SBS Transit, Bumitama Agri, SIA Engineering and Oxley Holdings.

Two of the 5 companies, Hi-P International and SBS Transit reported net profit growth for their 9MFY19 through to 30 Sep. SIA Engineering also reported net profit growth for its 1HFY19/20 through to 30 Sep and Oxley Holdings also reported net profit for its 1QFY20 through to 30 Sep was $9.4 million, compared to a restated net loss of $3.9 million in its 1QFY19.

SBS Transit was also amongst the 5 best performers of the group in the preceding year, along with Japfa, Sheng Siong Group, ComfortDelGro and Haw Par Corporation. Hi-P International also led the current of Mid-Cap companies in total returns for 2017, with Oxley Holdings also amongst 2017’s best performers.


Singapore's Mid-Cap Companies - Strongest Gainers in 2019
  • HI-P INTERNATIONAL
  • SBS TRANSIT
  • BUMITAMA AGRI
  • SIA ENGINEERING CO
  • OXLEY HOLDINGS 

Singapore's Mid-Cap Companies - Strongest Gainers in 2018
  • JAPFA 
  • SHENG SIONG GROUP
  • COMFORTDELGRO CORP
  • SBS TRANSiT 
  • HAW PAR CORP 

Singapore's Mid-Cap Companies - Strongest Gainers in 2017
  • HI-P INTERNATIONAL
  • VENTURE CORP
  • YANGZIJIANG SHIPBUILDING
  • OXLEY HOLDINGS
  • MANDARIN ORIENTAL INTL


5 Mid-Caps with Largest Net Institutional Inflows All Outpaced STI

Overall, the 40 Mid-Cap Companies were recipient of S$143.6 million in net institutional outflow in 2019.

All 5 stocks that were recipient to the largest net institutional inflows of the 40 companies in 2019 outpaced the STI for the year. These 5 stocks were ComfortDelGro, SATS, Hi-P International, GuocoLand and Sheng Siong Group. The broader group of 10 stocks that were recipient to the largest net institutional inflows among the 40 companies last year averaged 18% total returns, with the median total return at 13%. Meanwhile, the 10 stocks that saw the largest net institutional outflows in 2019 averaged a 4% decline in total return, with the median decline in total return at 8%. 

With net institutional inflows ranked proportionate to market capitalisation as of the end of 2019, the average of the 10 stocks that ranked the highest in the more congruent measure averaged a 23% total return with the median total return at 14%. These 10 stocks were Hi-P International, ComfortDelGro, Sheng Siong Group, GuocoLand, Thomson Medical Group, SBS Transit, SATS, First Resources, Singapore Press Holdings and Singapore Post.

The full list of the 40 most traded Mid-Cap companies in 2019, sort by year-end market capitalisation are tabled below.

Name SGX
Code
Market
Cap
S$m
Price
Change
2019
Volatility
2019
Total
Return
2019
Total
Return
2018
Total
Return
2017
Net
Instituition
Inflow
S$m
Average
Daily
Turnover
2019
(SS$,000)
OLAM INTERNATIONAL BS6 5,767 10% 22% 14% -16% 6% 13.9 1,017
SATS V03 5,658 9% 16% 13% -7% 11% 33.2 8,694
COMFORTDELGRO C52 5,155 11% 21% 15% 14% -16% 70.9 18,153
FRASERS PROPERTY T39 4,946 2% 17% 7% -17% 39% 2.0 425
VENTURE CORP S58 4,673 16% 31% 21% -29% 115% -4.8 19,936
YANGZIJIANG SHIPBUILDING U96 4,389 -10% 46% -7% -11% 86% 13.6 34,451
UNITED INDUSTRIAL CORP S51 4,111 5% 14% 6% -17% 21% -4.3 168
SEMBCORP INDUSTRIES H17 4,089 -10% 23% -8% -15% 9% -90.3 8,046
SINGAPORE PRESS HOLDINGS E5H 3,476 -7% 21% -2% -7% -21% 14.9 10,359
SIA ENGINEERING CO CC3 3,159 24% 20% 29% -25% -3% -6.2 1,457
MANDARIN ORIENTAL INTL S08 3,092 -12% 28% -10% 4% 50% -0.5 579
FIRST RESOURCES Z25 3,010 23% 26% 25% -14% 0% 13.5 1,672
GOLDEN AGRI-RESOURCES EB5 2,993 -4% 45% -2% -34% -11% -7.8 6,699
HAW PAR CORP OV8 2,827 6% 16% 15% 8% 27% -12.0 874
SEMBCORP MARINE S59 2,762 -14% 33% -14% -16% 35% -56.3 7,797
FRASER AND NEAVE UD2 2,494 0% 15% 3% -32% 26% -10.6 166
STARHUB BSL 2,459 -19% 24% -13% -33% 8% -93.1 3,973
YANLORD LAND GROUP O32 2,337 -1% 29% 4% -22% 26% -15.8 2,500
GUOCOLAND 5CP 2,319 9% 15% 13% -16% 28% 25.1 471
SINGAPORE POST G92 2,104 2% 15% 6% -24% -14% 7.9 2,738
HOTEL PROPERTIES H02 2,006 7% 17% 10% -6% 5% 4.5 301
SHENG SIONG GROUP 5UX 1,864 17% 15% 21% 18% 1% 21.4 1,624
RAFFLES MEDICAL GROUP A50 1,828 -9% 17% -7% 0% -20% -20.5 1,350
TIANJIN ZHONG XIN PHARM CO-S W05 1,752 -1% 22% 2% -2% -1% -7.5 359
THOMSON MEDICAL GROUP B61 1,692 -12% 30% -12% -42% 5% 14.6 802
HO BEE LAND M04 1,603 2% 13% 6% 0% 24% -3.0 147
WING TAI HOLDINGS F17 1,553 5% 12% 7% -12% 47% -7.5 686
OXLEY HOLDINGS TQ5 1,501 22% 30% 26% -45% 72% 0.6 809
BUMITAMA AGRI T14 1,390 29% 29% 34% -13% -8% -3.0 326
OUE LJ3 1,344 4% 19% 13% -22% 8% -0.5 342
HI-P INTERNATIONAL P8Z 1,232 73% 51% 101% -51% 327% 28.4 6,978
BUKIT SEMBAWANG ESTATES S41 1,212 -17% 13% -14% -7% 47% -34.1 617
HONG LEONG FINANCE H15 1,198 5% 12% 11% -2% 32% -12.4 319
SBS TRANSIT B16 1,194 42% 22% 47% 12% 21% 9.2 224
FIRST SPONSOR GROUP S61 1,106 9% 17% 11% 2% 7% 0.4 42
GL U06 1,101 10% 14% 13% -10% 13% -1.3 299
CHINA AVIATION OIL SINGAPORE F99 1,092 20% 25% 24% -33% 19% -4.3 915
SILVERLAKE AXIS H13 1,081 -1% 29% 3% -25% 19% -13.2 982
JAPFA ADN 1,081 -21% 37% -18% 45% -43% -18.3 1,367
SINARMAS LAND A26 1,064 0% 41% 1% -36% -4% -1.6 34
Average     6% 24% 10% -13% 25%
Median     4% 21% 7% -15% 12%

Source: SGX StockFacts, Thomson Reuters, Bloomberg (Data as of 31 December 2019).



As discussed here, total returns are accumulative returns and assume dividends are reinvested into units or shares on the ex-dividend date. Note 2019 best performers do not include CITIC Envirotech and United Engineers due to recent developments in cash offers. A formal exit offer was made for CITIC Envirotech on 3 January (click here) with an exit offer price of S$0.55 a share that represents a 68.5% premium over the VWAP of S$0.326 for the three month period up to and including 1 Nov 2019.







This article is provided by SGX My Gateway.



SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the SGX Group Companies) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.












Stock / REIT Search

Advertisement

Advertisement